GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Byotrol PLC (LSE:BYOT) » Definitions » Institutional Ownership

Byotrol (LSE:BYOT) Institutional Ownership : 1.05% (As of May. 13, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Byotrol Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Byotrol's institutional ownership is 1.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Byotrol's Insider Ownership is 11.36%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Byotrol's Float Percentage Of Total Shares Outstanding is 0.00%.


Byotrol Institutional Ownership Historical Data

The historical data trend for Byotrol's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Byotrol Institutional Ownership Chart

Byotrol Historical Data

The historical data trend for Byotrol can be seen below:

2021-02-28 2021-03-31 2021-04-30 2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30 2021-10-31 2021-11-30
Institutional Ownership 1.55 1.55 1.55 1.52 1.52 1.52 1.52 1.52 1.52 1.05

Byotrol Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Byotrol (LSE:BYOT) Business Description

Traded in Other Exchanges
Address
Building 303 (Ashton), Pool Lane, Thornton Science Park, Ince, Chester, GBR, CH2 4NU
Byotrol PLC is a developer of consumer and professional antimicrobial technologies and products. It is engaged in the development, patenting, licensing, and sale of anti-microbial products and technologies for business and consumer use. It operates in two reportable segments, being Professional (including Human Health, Animal Health, Facilities Management, and Food & Beverage), and Consumer (Including Household, Skin Care, and Pet Care). Its customers are based in the UK, North America, Asia, and the Rest of the World. The company generates key revenue from product sales - sale of anti-microbial technology and includes Royalty and licensing income.

Byotrol (LSE:BYOT) Headlines

No Headlines